Noncompliance with congestive heart failure therapy in the elderly.

BACKGROUND Noncompliance with long-term medication regimens, such as those employed in the treatment of congestive heart failure (CHF), has been found to be approximately 50%. However, no evaluation has been performed on a population-based cohort of elderly patients beginning the use of digoxin and followed up longitudinally for an extended observation period. METHODS To study patterns of medication compliance, we conducted a retrospective follow-up of 7247 outpatients aged 65 to 99 years newly prescribed digoxin between 1981 and 1991, with the use of the complete prescription claims file of the New Jersey Medicaid program. Noncompliance was measured in terms of the number of days during the 12-month period after an initial digoxin prescription in which no CHF medication was available to the patient. RESULTS Patients started on a regimen of digoxin were without digoxin or any other common alternative CHF drug for an average of 111 of the 365 days of follow-up. Only 10% of the population filled enough prescriptions to have daily CHF medication available for the entire year of follow-up. Compliance rates were higher in patients over 85 years of age, women, those taking multiple medications, and those with hospital or nursing home stays before the initiation of therapy. CONCLUSIONS A large proportion of patients who begin digoxin therapy end CHF therapy or consume substantially less medication than expected in the first year of therapy. Such high rates of cessation could represent an important impediment to effective CHF therapy.

[1]  S. Rahimtoola The pharmacologic treatment of chronic congestive heart failure. , 1989, Circulation.

[2]  G. D. Johnston,et al.  Do patients take digoxin? , 1978, British heart journal.

[3]  Current role of digitalis therapy in patients with congestive heart failure. , 1991, JAMA.

[4]  J. Avorn,et al.  Antihypertensive Drug Therapy and the Initiation of Treatment for Diabetes Mellitus , 1993, Annals of Internal Medicine.

[5]  B. Gersh,et al.  Heart disease in the elderly. , 1987, Current problems in cardiology.

[6]  J. D. Robinson,et al.  Prediction of serum concentrations of digoxin in a family practice center. , 1982, The Journal of family practice.

[7]  W. Schaffner,et al.  Medicaid Records as a Valid Data Source: The Tennessee Experience , 1976, Medical care.

[8]  L. Perkins,et al.  Symptom Prevalence in the Elderly , 1986, Journal of the American Geriatrics Society.

[9]  M. Wilén,et al.  Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. , 1988, JAMA.

[10]  M. Gheorghiade,et al.  Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. , 1989, Journal of the American College of Cardiology.

[11]  M. Kass,et al.  Compliance with topical timolol treatment. , 1987, American journal of ophthalmology.

[12]  J. Avorn,et al.  Drug prescribing for the elderly. , 1986, Archives of internal medicine.

[13]  Stephen B. Soumerai,et al.  Improving Drug-Therapy Decisions through Educational Outreach , 1983 .

[14]  R. Schlant,et al.  A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. , 1989, The New England journal of medicine.

[15]  C. Francis Hypertension, cardiac disease, and compliance in minority patients. , 1991, The American journal of medicine.

[16]  S. Fletcher,et al.  Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxin. , 1979, Archives of internal medicine.

[17]  K. O’malley,et al.  Prescribing for the Elderly: Part II Prescribing Patterns: Differences Due to Age , 1988, Journal of the American Geriatrics Society.

[18]  B. Kirkman-Liff,et al.  Language of interview: relevance for research of southwest Hispanics. , 1991, American journal of public health.

[19]  S. Mcphee,et al.  Knowledge of and Compliance with Drug Regimens in the Elderly , 1982, Journal of the American Geriatrics Society.

[20]  M. Murray,et al.  Medication Use By Ambulatory Elderly , 1986, Journal of the American Geriatrics Society.

[21]  V. Froelicher,et al.  Increased exercise capacity after digoxin administration in patients with heart failure. , 1989, Journal of the American College of Cardiology.

[22]  W. Barclay AMA drug evaluations. , 1977, JAMA.

[23]  J. Kirscht,et al.  Understanding and improving patient compliance. , 1984, Annals of internal medicine.

[24]  R. Miller,et al.  Quantifying non-compliance in patients receiving digoxin--a pharmacokinetic approach. , 1991, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[25]  R. Stewart,et al.  Medication compliance in the elderly. , 1989, The Medical clinics of North America.

[26]  G. Guyatt,et al.  A controlled trial of digoxin in congestive heart failure. , 1988, The American journal of cardiology.

[27]  J. Avorn,et al.  Treatment for glaucoma: adherence by the elderly. , 1993, American journal of public health.